Scalp microbiome as a key factor in hair growth: innovative therapeutic strategies
Creators
Description
Introduction. Disruption of the scalp microbiome is one of the key factors in the development of seborrheic dermatitis, itching, scaling, increased oiliness and diffuse hair loss. Traditional aggressive treatment approaches using antifungal, antibacterial or corticosteroid agents are often accompanied by side effects, disruption of the skin microflora and relapses. In this context, there is a need for alternative, microbiome-friendly innovative therapeutic strategies. The purpose of the study was to evaluate the effectiveness of probiotics, prebiotics, postbiotics and recombinant peptides in the care of scalps with a disturbed microbiome, as well as to determine their effect on symptoms, microbiota structure and hair growth. Materials and methods of the study included a systematic review of the literature on the assessment of dynamics in individuals with scalp microbiome disorders, the use of molecular diagnostic methods, trichoscopy, questionnaires and dermatological indices. analysis of the composition of cosmetic products, the results obtained were analyzed using descriptive statistics. As a result, it was found that microbiome-friendly products help reduce itching, redness, peeling, normalize sebum secretion and improve subjective comfort. Also recorded was an increase in microbiome diversity, a decrease in the concentration of Cutibacterium acnes and Malassezia spp., activation of the anagen phase of hair growth, a decrease in telogen effluvium and positive changes in diffuse alopecia. Conclusions. The comparative analysis confirmed the advantages of innovative microbiome-friendly therapy over traditional aggressive therapy: higher safety, better tolerability, a lasting effect and the possibility of personalizing treatment. The data obtained indicate the feasibility of introducing such products into clinical practice for the treatment of dysbiotic scalp conditions.
Files
malamiuk_ShapovalovaFIN.pdf
Files
(474.1 kB)
Name | Size | Download all |
---|---|---|
md5:6c5488b30a1bbf4639b81f0455dc960b
|
474.1 kB | Preview Download |
Additional details
References
- 1. Gallinée. The Science Behind the Scalp Microbiome. 2023. URL: https://www.gallinee.com.
- 2. Townsend N., Hazan A., Dell'Acqua G. New Topicals to Support a Healthy Scalp While Preserving the Microbiome: A Report of Clinical and in Vitro Studies. The Journal of Clinical and Aesthetic Dermatology. 2023. Vol. 16. No. 10. P. S4–S11. URL: https://jcadonline.com/new-topicals-to-support-a-healthy-scalp-while-preserving-the-microbiome.
- 3. Shapovalov V., Shapovalova V., Titarenko I., Osyntseva A., Shapovalov V. Chronic pancreatitis: Pharmacotherapy, prescription of drugs, meta-analysis, latest digital medical technologies of quantum medicine. Revista Colombiana de Ciencias Químico-Farmacéuticas. 2025. Vol. 54. No. 2. P. 475–489. DOI: https://doi.org/10.15446/rcciquifa.v54n2.117235. URL: https://revistas.unal.edu.co/index.php/rccquifa/article/view/117235
- 4. Shapovalova V. Alcoholic Hepatitis: an experimental Meta-Analysis. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.1. P.1-11. URL: https://doi.org/10.53933/sspmpm.v3i1.77
- 5. Pickart L., Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018. Vol. 19. No. 7. P. 1987. DOI: https://doi.org/10.3390/ijms19071987.
- 6. Tsai W.H., Fang Y.T., Huang T.Y. et al. Heat-killed Lacticaseibacillus paracasei GMNL-653 ameliorates human scalp health by regulating scalp microbiome. BMC Microbiology. 2023. Vol. 23. No. 121. DOI: https://doi.org/10.1186/s12866-023-02870-5.
- 7. Salem I., Ramser A., Isham N. et al. The Gut Microbiome as a Major Regulator of the Gut-Skin Axis. Frontiers in Microbiology. 2018. Vol. 9. P. 1459. DOI: https://doi.org/10.3389/fmicb.2018.01459.
- 8. Dermatology Life Quality Index. The UK-Irish Atopic Eczema Systemic Therapy. A-Star. URL: https://ppopderm.org/app/uploads/2024/10/DLQI-ASTAR-V1-18Jul18.pdf
- 9. Navarro-Belmonte M.R., Aguado-García Á., Sánchez-Pellicer P. et al. The effect of an oral Probiotic mixture on clinical evolution and the gut and Skin Microbiome in patients with Alopecia Areata: a randomized clinical trial. Cosmetics. 2024. Vol. 11. No. 4. P. 119. DOI: https://doi.org/10.3390/cosmetics11040119.
- 10. De Giani A., Sandionigi A., Zampolli J. et al. Effects of Inulin-based Prebiotics alone or in combination with Probiotics on human gut microbiota and markers of immune system: a randomized, double-blind, placebo-controlled study in healthy subjects. Microorganisms. 2022. Vol. 10. No. 6. P. 1256. DOI: https://doi.org/10.3390/microorganisms10061256
- 11. Inulin: The natural Prebiotic powerhouse for skin and hair. Abyssian Haircare. 2022. URL: https://www.abyssianhaircare.com/blogs/ingredientslibrary/inulin-the-natural-prebiotic-powerhouse-for-skin-and-hair.
- 12. Probiotics. Cleveland clinic. 2023. URL: https://my.clevelandclinic.org/health/treatments/14598-probiotics
- 13. Honda K., Littman D.R. The microbiota in adaptive immune homeostasis and disease. Nature. 2016. Vol.535. Iss.75. p. 75-84. DOI: 10.1038/nature18848.
- 14. Sreenivas Sh., King L. Peptides: types, uses, and benefits. WebMD. 15.02.2024.URL: https://www.webmd.com/a-to-z-guides/what-are-peptides
- 15. Ahmed I., Roy B., Khan S. et al. Microbiome, metabolome and inflammatory bowel disease. Microorganisms. 2016. No. 4. Р. 20. URL: https://pubmed.ncbi.nlm.nih.gov/27681914/
- 16. Muel N., Bacacs E., Combellick J. et al. The microbiome development. Trends Mol. Med. 2015. No. 21. Р. 109–117. https://pubmed.ncbi.nlm.nih.gov/25578246/
- 17. Shapovalov V.V. (Jr), Zbrozhek S.I., Shapovalova V.O., et al. Organizational and legal evaluation of availability of medicines' circulation for cancer patients. Pharmacia. 2018. Vol. 65. No. 2. P. 17–22. URL: https://bsphs.org/wp-content/uploads/magazine/2018/2/Shapovalov.pdf
- 18. Nevzghoda O.A., Shapovalov V.V., Shapovalova V.O., Osyntseva A.O., Shapovalov V.V., Protsiuk R.H. Optimisation of antibiotic selection: ABC and VED analysis of medicines against intracellular microorganisms. Tuberculosis, Pulmonary Diseases, HIV-infection. 2025. No. 3 (62). P. 68–79. DOI: http://doi.org/10.30978/TB2025-3-68.